Skip to main navigation Skip to search Skip to main content

Characterization of a Novel Inhibitor of Myelination: MAPK12/P38MAPKgamma

Project: Research

Project Details

StatusFinished
Effective start/end date10/1/1409/30/18

Funding

  • National Multiple Sclerosis Society: $596,536.60